Products found to contain undeclared medicines
|
| |
| The United States: Updated Company Announcement to August 28, 2025 Recall Announcement: Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings |
| |
The United States Food and Drug Administration (FDA) announces that Green Lumber Holding, LLC (“Green Lumber”) is issuing an updated consumer alert regarding counterfeit products falsely marketed as genuine Green Lumber products that may pose potential health risks.
This update follows the FDA February 9 publication in its Enforcement Report referencing Green Lumber’s original recall, which was initiated on August 28, 2025. The recall was issued in late August 2025 after FDA testing detected tadalafil—an undeclared prescription drug—in products labeled as Green Lumber. Tadalafil is not an ingredient in any authentic Green Lumber product. The February 9 Enforcement Report does not announce a new recall; it reflects publication of the previously announced August 28, 2025, recall.
Following the FDA’s findings, Green Lumber conducted an internal investigation and determined that a company employee had misappropriated legitimate packaging and customer information to distribute counterfeit or adulterated products. That employee has been terminated.
The counterfeit recalled product bears the Lot Number LOT308EXP03/28. The counterfeit versions may contain undeclared tadalafil. Because tadalafil is a prescription-only medication, individuals who take nitrates or certain prescription drugs for heart disease, blood pressure, or other conditions may be at risk of life-threatening side effects such as dangerously low blood pressure or other serious adverse events.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/updated-company-announcement-august-28-2025-recall-announcement
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 21 Sep 2019, 24 Oct 2019, 16 Aug 2025 and 30 Aug 2025.
Ends/ Saturday, February 14, 2026
Issued at HKT 12:00
|
| |
|
